Global Blood Screening Market to reach USD 4.45 billion by 2026

Global Blood Screening Market Size Study, by Technology (NAT, Rapid Test, Western Blot Assay, NGS) by Product & Service (Reagents & Kits, Instruments, Software & Services) by End Use (Blood Banks, Hospitals) by Regional Forecasts 2019-2026
Product Code:  HALMD_29768368
Chapter 1.	Executive Summary  
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1.	Blood Screening Market, by Technology, 2017-2026 (USD Billion)
1.2.2.	Blood Screening Market, by Product & Service, 2017-2026 (USD Billion)
1.2.3.	Blood Screening Market, by End-Use, 2017-2026 (USD Billion)
1.2.4.	Blood Screening Market, by Region, 2017-2026 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Blood Screening Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Blood Screening Market Dynamics	
3.1.	Blood Screening Market Impact Analysis (2018-2026)
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Blood Screening Market Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Blood Screening Market, by Technology 
5.1.	Market Snapshot 
5.2.	Global Blood Screening Market by Technology, Performance - Potential Analysis
5.3.	Global Blood Screening Market Estimates & Forecasts by Technology 2016-2026 (USD Billion)
5.4.	Blood Screening Market, Sub Segment Analysis 
5.4.1.	Nucleic Acid Test (NAT)
5.4.2.	Rapid Test
5.4.3.	Western Blot Assay 
5.4.4.	Next-Generation Sequencing (NGS)
Chapter 6.	Global Blood Screening Market, by Product & Service 
6.1.	Market Snapshot 
6.2.	Global Blood Screening Market by Product & Service, Performance - Potential Analysis
6.3.	Global Blood Screening Market Estimates & Forecasts by Product & Service, 2016-2026 (USD Billion)
6.4.	Blood Screening Market, Sub Segment Analysis
6.4.1.	Reagents & Kits 
6.4.2.	Instruments 
6.4.3.	Software & Service
Chapter 7.	Global Blood Screening Market, by End-Use 
7.1.	Market Snapshot 
7.2.	Global Blood Screening Market by End-Use, Performance - Potential Analysis
7.3.	Global Blood Screening Market Estimates & Forecasts by End-Use, 2016-2026 (USD Billion)
7.4.	Blood Screening Market, Sub Segment Analysis
7.4.1.	Blood Bank 
7.4.2.	Hospital
Chapter 8.	Global Blood Screening Market, Regional Analysis
8.1.	Blood Screening Market, Regional Market Snapshot 
8.2.	North America Blood Screening Market 
8.2.1.	U.S. Blood Screening Market
8.2.1.1.	Technology breakdown estimates & forecasts, 2016-2026
8.2.1.2.	Product & Service breakdown estimates & forecasts, 2016-2026
8.2.1.3.	End-Use breakdown estimates & forecasts, 2016-2026
8.2.2.	Canada Blood Screening Market
8.3.	Europe Blood Screening Market Snapshot
8.3.1.	U.K. Blood Screening Market
8.3.2.	Germany Blood Screening Market
8.3.3.	Rest of Europe Blood Screening Market
8.4.	Asia-Pacific Blood Screening Market Snapshot
8.4.1.	China Blood Screening Market 
8.4.2.	India Blood Screening Market 
8.4.3.	Japan Blood Screening Market
8.4.4.	Rest of Asia Pacific Blood Screening Market
8.5.	Latin America Blood Screening Market Snapshot
8.5.1.	Brazil Blood Screening Market
8.5.2.	Mexico Blood Screening Market
8.6.	Rest of The World Blood Screening Market
Chapter 9.	Competitive Intelligence
9.1.	Top Market Strategies
9.2.	Company Profiles
9.2.1.	Grifols 
9.2.1.1.	Overview
9.2.1.2.	Financial (Subject to Data Availability)
9.2.1.3.	Product Summary
9.2.1.4.	Recent Developments
9.2.2.	 F. Hoffmann-La Roche 
9.2.3.	Abbott Laboratories
9.2.4.	Biomerieux 
9.2.5.	Bio-Rad Laboratories, Inc. 
9.2.6.	Siemens Healthineers 
9.2.7.	Ortho Clinical Diagnostics, Inc. 
9.2.8.	Thermo Fisher Scientific, Inc. 
9.2.9.	Beckman Coulter 
9.2.10.	Becton, Dickinson & Company 
Chapter 10.	Research Process
10.1.	Research Process
10.1.1.	Data Mining
10.1.2.	Analysis
10.1.3.	Market Estimation
10.1.4.	Validation
10.1.5.	Publishing
10.2.	Research Attributes
10.3.	Research Assumption

Global Blood Screening Market valued approximately USD 2.12 billion in 2018 is anticipated to grow with a healthy growth rate of more than 9.7% over the forecast period 2019-2026. Initiatives by the various organizations and governments increase awareness about donation and screening before transfusion. According to the WHO, approximately 108 million blood donations are collected every year across the globe. About 50% of these blood donations collected from high-income countries which is home to less than 20% of the total population. Hence, rising awareness coupled with the high demand for safe blood create opportunities in emerging countries. Growing numbers of blood donations and blood donors with growing consciousness about preserving donated blood and growing occurrence of transferable illnesses, growing call for donated blood, rise in spending on fitness, technical developments in blood screening, growing alertness for fitness and increasing number of initiatives by many administrations and government associations are a few important issues motivating the development of the global blood screening market size. Yet, composite controlling outlines for sanction, shortage of expert manpower, existence of another know-how like digital immunoassay associated with high original investment expenditure and operative costs of testing are the limiting issues for the development of the global blood screening market size.

The major manufacturers involved in this report are:
Grifols
F. Hoffmann-La Roche
Abbott Laboratories
Biomerieux
Bio-Rad Laboratories, Inc.
Siemens Healthineers
Ortho Clinical Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Beckman Coulter
Becton, Dickinson & Company
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

By Technology:
Nucleic Acid Test (NAT)
Rapid Test
Western Blot Assay
Next-Generation Sequencing (NGS)

By Product & Services:
Reagents & Kits
Instruments
Software & Service

By End Use:
Blood Bank
Hospitals

By Regions:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Blood Screening Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…